When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OXFD - Oxford Immunotec's reagent for TB diagnosis OK'd in South Korea
Oxford Immunotec Global PLC
The South Korean regulatory authority has approved Oxford Immunotec's ([[OXFD]] +1.3%) T-Cell Select reagent kit, an immune cell separation reagent used to automate the preparation of the cells required to run the Company’s T-SPOT.TB test, for diagnosis of TB infection, from blood samples.The kit allows samples to be stored for up to 54 hours at room temperature before use.